Oei Ling, Hsu Yi-Hsiang, Styrkarsdottir Unnur, Eussen Bert H, de Klein Annelies, Peters Marjolein J, Halldorsson Bjarni, Liu Ching-Ti, Alonso Nerea, Kaptoge Stephen K, Thorleifsson Gudmar, Hallmans Göran, Hocking Lynne J, Husted Lise Bjerre, Jameson Karen A, Kruk Marcin, Lewis Joshua R, Patel Millan S, Scollen Serena, Svensson Olle, Trompet Stella, van Schoor Natasja M, Zhu Kun, Buckley Brendan M, Cooper Cyrus, Ford Ian, Goltzman David, González-Macías Jesús, Langdahl Bente Lomholt, Leslie William D, Lips Paul, Lorenc Roman S, Olmos José M, Pettersson-Kymmer Ulrika, Reid David M, Riancho José A, Slagboom P Eline, Garcia-Ibarbia Carmen, Ingvarsson Thorvaldur, Johannsdottir Hrefna, Luben Robert, Medina-Gómez Carolina, Arp Pascal, Nandakumar Kannabiran, Palsson Stefan Th, Sigurdsson Gunnar, van Meurs Joyce B J, Zhou Yanhua, Hofman Albert, Jukema J Wouter, Pols Huibert A P, Prince Richard L, Cupples L Adrienne, Marshall Christian R, Pinto Dalila, Sato Daisuke, Scherer Stephen W, Reeve Jonathan, Thorsteinsdottir Unnur, Karasik David, Richards J Brent, Stefansson Kari, Uitterlinden André G, Ralston Stuart H, Ioannidis John P A, Kiel Douglas P, Rivadeneira Fernando, Estrada Karol
Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
J Med Genet. 2014 Feb;51(2):122-31. doi: 10.1136/jmedgenet-2013-102064. Epub 2013 Dec 16.
Osteoporosis is a systemic skeletal disease characterised by reduced bone mineral density and increased susceptibility to fracture; these traits are highly heritable. Both common and rare copy number variants (CNVs) potentially affect the function of genes and may influence disease risk.
To identify CNVs associated with osteoporotic bone fracture risk.
We performed a genome-wide CNV association study in 5178 individuals from a prospective cohort in the Netherlands, including 809 osteoporotic fracture cases, and performed in silico lookups and de novo genotyping to replicate in several independent studies.
A rare (population prevalence 0.14%, 95% CI 0.03% to 0.24%) 210 kb deletion located on chromosome 6p25.1 was associated with the risk of fracture (OR 32.58, 95% CI 3.95 to 1488.89; p = 8.69 × 10(-5)). We performed an in silico meta-analysis in four studies with CNV microarray data and the association with fracture risk was replicated (OR 3.11, 95% CI 1.01 to 8.22; p = 0.02). The prevalence of this deletion showed geographic diversity, being absent in additional samples from Australia, Canada, Poland, Iceland, Denmark, and Sweden, but present in the Netherlands (0.34%), Spain (0.33%), USA (0.23%), England (0.15%), Scotland (0.10%), and Ireland (0.06%), with insufficient evidence for association with fracture risk.
These results suggest that deletions in the 6p25.1 locus may predispose to higher risk of fracture in a subset of populations of European origin; larger and geographically restricted studies will be needed to confirm this regional association. This is a first step towards the evaluation of the role of rare CNVs in osteoporosis.
骨质疏松症是一种全身性骨骼疾病,其特征为骨矿物质密度降低以及骨折易感性增加;这些特征具有高度遗传性。常见和罕见的拷贝数变异(CNV)都可能影响基因功能并可能影响疾病风险。
鉴定与骨质疏松性骨折风险相关的CNV。
我们对来自荷兰一个前瞻性队列的5178名个体进行了全基因组CNV关联研究,其中包括809例骨质疏松性骨折病例,并进行了电子模拟查找和从头基因分型,以在多项独立研究中进行复制。
位于6号染色体p25.1上的一个罕见(人群患病率0.14%,95%可信区间0.03%至0.24%)的210 kb缺失与骨折风险相关(比值比32.58,95%可信区间3.95至1488.89;p = 8.69×10⁻⁵)。我们对四项具有CNV微阵列数据的研究进行了电子模拟荟萃分析,与骨折风险的关联得到了复制(比值比3.11,95%可信区间1.01至8.22;p = 0.02)。这种缺失的患病率显示出地理多样性,在来自澳大利亚、加拿大、波兰、冰岛、丹麦和瑞典的其他样本中不存在,但在荷兰(0.34%)、西班牙(0.33%)、美国(0.23%)、英格兰(0.15%)、苏格兰(0.10%)和爱尔兰(0.06%)存在,与骨折风险关联的证据不足。
这些结果表明,6p25.1位点的缺失可能使欧洲裔人群的一个亚组骨折风险更高;需要进行更大规模且地域受限的研究来证实这种区域关联。这是评估罕见CNV在骨质疏松症中作用迈出的第一步。